Monitor for the S-1 registration statement and subsequent IPO pricing details, as this filing signals an IPO is imminent. No immediate trading catalyst from this routine ownership disclosure.
Price Chart
Executive Summary
Form 3 initial beneficial ownership filing by Frazier Life Sciences entities, reporting aggregate beneficial ownership of approximately 5.6 million shares of Attovia Therapeutics on an as-converted basis. The filing is a standard IPO-related disclosure by major pre-IPO investors and contains no material changes to operations or financials.
Key Facts
- Frazier Life Sciences XI, L.P. directly holds 75,349 shares of Attovia common stock.
- FHMLS XI, L.P. holds conversion rights on preferred stock representing 1,749,192 (Series A-1), 1,590,175 (Series A-2), 1,189,940 (Series B), and 961,322 (Series C) shares of common stock, all convertible upon IPO closing.
- Preferred stock automatically converts to common stock upon closing of the IPO.
Financial Impact
No financial data reported in filing
Risk Factors
- No material risks identified from this filing
- IPO dilution and lock-up expiry post-IPO are standard risks but not addressed in this form
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (ATTO) — Batch item 1 | 0001231919-26-000827 |
| Document: 0001231919-26-000827-index.html | 0001231919-26-000827 |
| Document: 0001231919-26-000827.txt | 0001231919-26-000827 |
| 3 Filing (ATTO) — Batch item 4 | 0001231919-26-000827 |
| Document: 0001231919-26-000827-index.html | 0001231919-26-000827 |
| Document: 0001231919-26-000827.txt | 0001231919-26-000827 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $13.88 (−14.37%) |
Oct 8, 2026 18d ago | 3/A | $16.21 | awaiting T+20 | — | $13.88 (−14.37%) |
Sep 28, 2026 28d ago | Press Release | $18.16 | awaiting T+20 | — | $13.88 (−23.57%) |
Sep 2, 2026 7w ago | Press Release | $24.20 $17.14 | ▼ −29.17% | ▼ −28.06% | $13.88 (−42.64%) |
Aug 28, 2026 8w ago | 144 / CLUSTER | $21.40 $18.16 | ▼ −15.14% | ▼ −14.95% | $13.88 (−35.14%) |
Aug 13, 2026 10w ago | Insider Buy | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $13.88 (−30.11%) |
Aug 13, 2026 10w ago | Insider Cluster | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $13.88 (−30.11%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.65 $22.86 | ▲ +22.57% | ▲ +23.63% | $13.88 (−25.58%) |
Aug 7, 2026 11w ago | Insider Cluster | $19.84 $23.66 | ▲ +19.25% | ▲ +20.17% | $13.88 (−30.04%) |
Aug 7, 2026 11w ago | Insider Cluster | $20.17 $25.55 | ▲ +26.67% | ▲ +27.07% | $13.88 (−31.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers